Expression of MN/CA9 protein in papanicolaou smears containing atypical glandular cells of undetermined significance is a diagnostic biomarker of cervical dysplasia and neoplasia

Cancer

Volumn 88, Issue 5, 2000, Pages 1108-1121

  Liao, Shu Yuan ^a,b   Stanbridge, Eric J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ST JOSEPH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ADULT; ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; CYTODIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE MARKER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PAPANICOLAOU TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DYSPLASIA;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0034162457     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000301)88:5<1108::AID-CNCR23>3.0.CO;2-D     Document Type: Article

References (38)

1. NIH Consensus Statement (1). Cervical cancer. Bethesda, MD: NIH, 1996;14:1-18.
2. Sherman ME, Kurman RJ. Intraepithelial carcinoma of the cervix. Cancer 1998;83:2243-6.
3. Kurman RJ, Henson DE, Herbst AL, Noller KL, Schiffman MH. Interim guidelines for management of cervical cytology. JAMA 1994;271:1866-9.
4. McGonigle KF, Berek JS. Early stage squamous cell and adenocarcinoma of the cervix. Curr Opin Obstet Gynecol 1992;4:109-19.
5. Miller BE, Flax SD, Arheart K, Photopulos G. The presentation of adenocarcinoma of the uterine cervix. Cancer 1993; 72:1281-5.
6. Koss LG. Cervical (Pap) smear: new directions. Cancer 1993;71 (Suppl.):1406-12.
7. Ayer B, Pacey F, Greenberg M, Bousfield L. The cytologic diagnosis of adenocarcinoma in situ of the cervix uteri and related lesions. I. Adenocarcinoma in situ. Acta Cytol 1987; 31:397-411.
8. Pacey NF. Glandular neoplasms of the uterine cervix. In: Bibbo M, editor. Comprehensive cytopathology. Philadelphia: W.B. Saunders, 1991:243-55.
9. National Cancer Institute Workshop. The revised Bethesda System for reporting cervical/vaginal cytologic diagnosis: report of the 1991 Bethesda Workshop. JAMA 1992;267:1892.
10. Kurman RJ, Solomon D. In: The Bethesda system for reporting cervical/vaginal cytologic diagnoses. New York: Springer-Verlag, 1994:64-76.
11. Lee KR. Atypical glandular cells in cervical smears from women who have undergone cone biopsy: a potential diagnostic pitfall. Acta Cytol 1993;37:705-9.
12. Pacey F, Ayer B, Greenberg M. The cytologic diagnosis of adenocarcinoma in situ of the cervix uteri and related lesions. III. Pitfalls in diagnosis. Acta Cytol 1988;32:325-30.
13. Yahr LJ, Lee KR. Cytologic findings in microglandular hyperplasia of the cervix. Diagn Cytopathol 1991;7:248-51.
14. Novotny DB, Maygarden SJ, Johnson DE, Frable WJ. Tubal metaplasia: a frequent potential pitfall in the cytologic diagnosis of endocervical glandular dysplasia on cervical smears. Acta Cytol 1992;36:1-10.
15. Koss LG. Diagnostic cytology and its histopathologic bases. Volume 1. 4th edition. Philadelphia: J. B. Lippincott, 1992; 387:452-4.
16. Wilbur DC, Mulford DM, Sickel JZ, Atkinson KM. The problem of endocervical atypia: new cytologic presentations of normal endocervical cells. Mol Pathol 1994;38:808.
17. Goff BA, Atanasoff P, Brown E, Muntz HG, Bell DA, Rice LW. Endocervical glandular atypia in Papanicolaou smears. Obstet Gynecol 1992;79:101-4.
18. Lee KR, Manna EA, St. John T. Atypical endocervical glandular cells: accuracy of cytologic diagnosis. Diagn Cytopathol 1995;13:202-8.
19. Nasu I, Meurer W, Fu YS. Endocervical glandular atypia and adenocarcinoma: a correlation of cytology and histology. Int J Gynecol Pathol 1993;12:208-18.
20. Taylor R, Guerriere J, Nash JD, Henry MR, O'Connor DM. Atypical cervical cytology: colposcopic follow-up using The Bethesda System. J Reprod Med 1993;38:443-7.
21. Kennedy AW, Salmieri SS, Wirth SL, Biscotti CV, Tuason LJ, Travarca MJ. Results of the clinical evaluation of atypical glandular cells of undetermined significance (AGCUS) detected on cervical cytology screening. Gynecol Oncol 1996; 63:14-8.
22. Bose S, Kannan V, Kline TS. Abnormal endocervical cells: really abnormal? really endocervical? Am J Clin Pathol 1994; 101:708-13.
23. Ronnett BM, Manos MM, Ransley JE, Fetterman BJ, Kiney WK, Hurley LB, et al. Atypical glandular cells of undetermined significance (AGUS): cytopathologic features, histopathologic results, and human papillomavirus DNA detection. Hum Pathol 1999;30:816-25.
24. Zavada J, Zavadova Z, Pastorekova S, Ciampor F, Pastorek J, Zelnik V. Expression of MaTu-MN protein in human tumor cultures and in clinical specimens. Int J Cancer 1993;54:268-74.
25. Pastorek J, Pastorekova S, Callebaut I, Mornon JP, Zelnik V, Opavsky R, et al. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene 1994;9:2877-88.
26. Liao SY, Brewer C, Zavada J, Pastorek J, Pastorekova S, Manetta A, et al. Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinomas. Am J Pathol 1994;145:598-609.
27. Liao SY, Stanbridge EJ. Expression of the MN antigen in cervical Papanicolaou smears is an early diagnostic biomarker of cervical dysplasia. Cancer Epidemiol Biomarkers Prev 1996;5:549-57.
28. Dunn G, Everitt B. Clinical problems and statistical solutions. In: Clinical biostatistics. New York: Halstead Press, 1995:1-32.
29. Crum CP, Cibas ES, Lee KR. Criteria for grading squamous intraepithelial lesions. In: Pathology of early cervical neoplasia. New York: Churchill Livingstone, 1997:47-91.
30. Kurman RJ, Norris HJ, Wilkinson E. Tumors of the cervix, vagina, and vulva. In: Atlas of tumor pathology. 3rd series, Fascicle 4. Washington, DC: Armed Forces Institute of Pathology, 1992:37-139.
31. Miller BE, Flax SD, Arheart K, Photopulos G. The presentation of adenocarcinoma of the uterine cervix. Cancer 1993; 72:1281-5.
32. Crum CP, Cibas ES, Lee KR. Glandular precursors, adenocarcinomas, and their mimics. In: Pathology of early cervical neoplasia. New York: Churchill Livingstone, 1997:177-240.
33. Kim HS, Underwood D, Frable WJ. Adenocarcinoma in the cervicovaginal Papanicolaou smear: analysis of a 12-year experience. Diagn Cytopathol 1991;7:119-24.
34. Raab SS, Geisinger KR, Silverman JF, Thomas PA, Stanley MW. Interobserver variability of a Papanicolaou smear diagnosis of atypical glandular cells of undetermined significance. Am J Clin Pathol 1998;110:653-9.
35. Raab SS, Isacson C, Layfield LJ, Lenel JC, Slagel DD, Thomas PA. Atypical glandular cells of undetermined significance: cytologic criteria to separate clinically significant from benign lesions. Am J Clin Pathol 1995;104:574-82.
36. Raab SS, Snider TE, Potts SA, McDaniel HL, Robinson RA, Nelson DL, et al. Atypical glandular cells of undetermined significance: diagnostic accuracy and interobserver variability using select cytologic criteria. Am J Clin Pathol 1997;107: 299-307.
37. DiTomasso JP, Ramzy I, Mody DR. Glandular lesions of the cervix: validity of cytologic criteria used to differentiate reactive changes, glandular intraepithelial lesions and adenocarcinoma. Acta Cytol 1996;40:1127-35.
38. Poynor EA, Barakat RR, Hoskins WJ. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix. Gynecol Oncol 1995;57:158-64.